Vera van der Noord

5PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 08, 2026
Disrupting CDK9 activity suppresses triple-negative breast cancer and is enhanced by EGFR Inhibition.

Vera E van der Noord, Ronan P McLaughlin, Jessica S Karuntu

|Feb 24, 2023
Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia.

Qiuyu Liu, Nasi Liu, Vera van der Noord

|Sep 23, 2022
Targeting the Heterogeneous Genomic Landscape in Triple-Negative Breast Cancer through Inhibitors of the Transcriptional Machinery.

Vera E van der Noord, Bob van de Water, Sylvia E Le Dévédec

|Sep 09, 2022
Hypoxia Triggers TAZ Phosphorylation in Basal A Triple Negative Breast Cancer Cells.

Qiuyu Liu, Wanda van der Stel, Vera E van der Noord

|Sep 18, 2018
The blood mMDSC to DC ratio is a sensitive and easy to assess independent predictive factor for epithelial ovarian cancer survival.

S J A M Santegoets, A F de Groot, E M Dijkgraaf

Pageof 1

Frequent Collaborators

3 joint publications

Sylvia E Le Dévédec

2 joint publications

Qiuyu Liu

2 joint publications

Wanda van der Stel

2 joint publications

Erik H J Danen